BioMark Diagnostics Inc.
BUX
Rangering i aksjer
#26639
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Aksjekurs
$0.33433516
Sist synkronisert: 2026-10-20
Markedsverdi
$35.60M
Endring (1 dag)
-3.08%
Endring (1 år)
39.31%
Land
CA
Handel BioMark Diagnostics Inc. (BUX)
Kategori
Healthcare
Aksjeprishistorikk for BioMark Diagnostics Inc. (BUX)
Høyeste sluttskurs: $0.38 den 2026-10-01
Laveste sluttskurs: $0.35 den 2015-03-01
Laveste sluttskurs: $0.35 den 2015-03-01
Aksjeprishistorikk for BioMark Diagnostics Inc. fra 2015 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $20.95 | 47.94% |
CN
|
|
| $177.93 | 21.98% |
US
|
